Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Am Geriatr Soc. 2021 Mar 26;69(6):1490–1499. doi: 10.1111/jgs.17121

TABLE 3.

Prevalence of users of target anticholinergics or recommended alternatives among all primary care older adults by group and timea

Intervention Control p-Value for difference by timeb p-Value for difference by sitec
Target anticholinergics
 Preintervention 193/3135 (6.2%) 217/3275 (6.6%) 0.6326 0.0610
 Postintervention 187/3653 (5.1%) 222/3004 (7.4%)
Recommended alternatives
 Preintervention 440/3135 (14.0%) 580/3275 (17.7%) 0.1076 0.5360
 Postintervention 539/3653 (14.8%) 570/3004 (19.0%)
a

Cell denominators include patients with any visit data at the designated clinic site in the period indicated.

b

p-Value for estimating the probability of a target anticholinergic order being discontinued or a recommended alternative being active using a mixed effect logistic regression model with covariates of time period (pre/post), treatment site, and random effect to account for the correlations within clinics.

c

p-Value estimating the probability of a target anticholinergic order being discontinued or a recommended alternative being active using a mixed effect logistic regression model with covariates of time period (pre/post), treatment site, and random effect to account for the correlations within clinics.